MRKR
MRKR
NASDAQ · Biotechnology

Marker Therapeutics Inc

$1.46
+0.00 (+0.00%)
As of May 16, 2:24 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.76M
Net Income
-12,883,873
Gross Margin
Profit Margin
-343.0%
Rev Growth
-26.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.76M 5.13M 3.86M 4.10M
Gross Profit 2.51M 2.67M
Operating Income -13,655,990 -16,769,533 -161,214 -174,270
Net Income -12,883,873 -15,821,374 -155,305 -171,738
Gross Margin 65.0% 65.0%
Operating Margin -363.4% -327.1% -4.2% -4.2%
Profit Margin -343.0% -325.8% -4.0% -4.2%
Rev Growth -26.7% -26.7% +19.6% -4.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.32M 9.35M
Total Equity 11.45M 10.87M
D/E Ratio 0.81 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,529,283 -17,536,933 -205,551 -243,961
Free Cash Flow -168,121 -167,490